- Live market news
- Stocks
- SPRY
ARS Pharmaceuticals, Inc
SPRYStockUSA
2.65USD−0.40 (−13.11%)Live · 5 Nov, 20:59 UTC
Key figures
- Previous close
- 3.05
- Open
- 3.05
- Day range
- 2.60 – 3.095
- 52-week range
- —
- Volume
- 2.77M
Latest news on SPRYranked by Oyticker for market impact
- 25Impact
ARS Pharmaceuticals securities fraud class action lawsuit notice
A shareholder litigation firm is soliciting lead plaintiffs for a class action securities fraud lawsuit against ARS Pharmaceuticals. This is a routine legal notice with no new factual disclosure about the company's operations or financial condition.
SPRYPharmaceuticals - 45Impact
SPRY Subject to Securities Class Action Lawsuit
ARS Pharmaceuticals (SPRY) faces a class action lawsuit alleging securities law violations. The suit represents potential disclosure or misrepresentation claims typical of biotech litigation.
SPRYPharmaceuticalsBiotechnology
In detailthe same figures as in Oyticker Charts
Performance
1D−13.1%
Ranges & volume
Day2.60 – 3.095
52 weeks—
- Open
- 3.05
- Prev. close
- 3.05
Volume 2.77Mavg —
Risk · 1 year
Not enough historyRisk needs at least a month of daily sessions.
Seasonality
Not enough historySeasonality needs several months of data.
SEC filings
All its filingsWhat SPRY filed
- 5 Nov 2026
- 5 Nov 2026
- 13 Aug 2026
- 13 Aug 2026
- 17 Jul 2026
- 7 Jul 2026
- 25 Jun 2026
- 15 May 2026
- 15 May 2026
Investor communication
- 13 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.